In the latest issue of American Pharmaceutical Review, Rosa Rodríguez and Davide Garrisi discuss the likelihood of a future market for biosimilar versions of CAR-T therapies.
关于我们
PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product.
- 网站
-
https://www.ppd.com
PPD的外部链接
- 所属行业
- 研究服务
- 规模
- 超过 10,001 人
- 总部
- Wilmington，NC
- 类型
- 上市公司
- 领域
- clinical research、drug development、CRO、patient recruitment、laboratory、pharmaceutical、biotechnology、biopharma、biopharmaceutical、consulting、therapeutics、Functional Service Partnerships、consulting、Early Development、Post-Approval、medical writing、drug information、pharmacovigilance、biostatistics和bioanalytical
地点
PPD员工
动态
-
Discover the perspective of Travis Hardin, an executive director on our #respiratory and #infectiousdisease team, as he discusses his role in supporting clients with their asset development. ? https://bit.ly/3vMMloS
-
-
Explore the future of clinical trials. Access our on-demand webinar and discover how patient-first approaches are revolutionizing the industry. In this webinar, you'll learn about patient #recruitment strategies, how to enhance #patient engagement and the benefits of a patient-first approach. Gain insights from industry experts and stay ahead in the evolving landscape of #clinicalresearch.
Patient First: Enhancing Strategies for Effective Patient Engagement, Recruitment and Diversity in Clinical Trials
-
The #FSP model is transforming the #biotech industry by providing additional capabilities, resources and expertise to augment internal capabilities, improve efficiency, foster #innovation and drive faster #drugdevelopment. Dive into our latest blog to explore real-world examples and insights on how FSP engagements help biotech companies stay dynamic, flexible and agile to meet their timelines. ??
How FSP Models Augment Biotech Companies' Internal Capabilities
https://www.ppd.com
-
November is #NationalHealthySkinMonth! We leverage our extensive experience in clinical #dermatology research to drive advancements in treatments and improve outcomes for skin diseases. Partner with our dermatology experts to discover how we can achieve healthier skin together. ? https://bit.ly/418hSz7
-
-
We're feeling grateful for the insightful discussions and innovative presentations at #ACR24 in Washington, D.C. ?? When rheumatology comes together, it’s not just inspiring — it’s transformative. We're excited to see how new partnerships and projects will shape the future of the field!
-
-
?? Save the dates! We’re excited to return to San Francisco in the new year for the 43rd annual J.P. Morgan Healthcare Conference on Jan. 13-16. Let’s ensure your clinical development and funding strategies are aligned. ?? Email [email protected] to schedule a meeting with our team. #JPM2025 #JPM25
-
-
The Colorado chapter of our Community Action Councils (CACs) returned to Children's Hospital Colorado this year to knit blankets with patients and their siblings. Our colleagues are passionate about helping others and improving the communities where we live and work. Thermo Fisher Scientific fosters volunteer-led CACs at sites and regions around the world, resourcing colleagues to directly connect with local communities to provide rewarding volunteer opportunities and philanthropic support.
-
-
In this recent Drug Discovery & Development article, our patient #diversity experts explore strategies for how pharmaceutical and biotech companies can better empower and integrate sites with a track record of reaching #underserved communities to overcome well-documented diversity barriers.
How Sustained Community Outreach is Improving Clinical Trial Representation
https://www.drugdiscoverytrends.com
-
What a night in RTP! We were honored to receive numerous recognitions at the 2024 PharmaTimes Clinical Researcher of the Year - The Americas competition. ?? Clinical Researcher Company of the Year ?????? Gold, silver and bronze individual and team awards for more than 25 of our colleagues ?? Read more ? https://bit.ly/4hZWtOk
-
-
-
-
-
+1
-